MIM
CORZ

MetLife Investment Management’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

MetLife Investment Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-154,448
Closed -$201K – 2857
2022
Q3 		$201K Buy
154,448
+31,765
+26% +$67.6K ﹤0.01% 2303
2022
Q2 		$183K Buy
+122,683
New +$564K ﹤0.01% 2386

Other funds holding CORZ

PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $6.36B AUM 28.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
STA
Summit Trail Advisors New York $7.95B AUM 26.49% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

MetLife Investment Management's CORZ Position: Q4 2022 in Review

MetLife Investment Management sold out of Core Scientific, Inc. Common Stock (CORZ) in Q4 2022, closing a stake of 154,448 shares — an estimated $201K sold.

MetLife Investment Management first reported a position in CORZ in Q2 2022 and held it in 2 quarters. The position peaked at $201K in Q3 2022. 89 funds tracked by Wall St. Rank hold CORZ as of Q4 2022.

  • MetLife Investment Management reported no remaining Core Scientific, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • MetLife Investment Management sold 154,448 Core Scientific, Inc. Common Stock shares in Q4 2022, an estimated $201K.
  • MetLife Investment Management first reported a position in Core Scientific, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • MetLife Investment Management's Core Scientific, Inc. Common Stock position peaked at $201K in Q3 2022.
  • 89 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q4 2022.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.